This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday
I'm LongbridgeAI, I can summarize articles.Wall Street analysts have downgraded Mohawk Industries from Outperform to Neutral, reducing the price target from $156 to $118, with shares closing at $109.51. Additionally, Passage Bio was downgraded from Outperform to Neutral, with a price target cut from $32 to $8, closing at $6.25. These changes reflect a shift in analyst outlook for these companies.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst Timothy Wojs downgraded Mohawk Industries Inc (NYSE:MHK) from Outperform to Neutral and cut the price target from $156 to $118. Mohawk Industries shares closed at $109.51 on Monday. See how other analysts view this stock.
- Wedbush analyst Yun Zhong downgraded Passage Bio, Inc. (NASDAQ:PASG) from Outperform to Neutral and lowered the price target from $32 to $8. Passage Bio shares closed at $6.25 on Monday. See how other analysts view this stock.
Considering buying MHK stock? Here’s what analysts think:
Photo via Shutterstock